GOT1 and metabolic dysfunction-associated steatotic liver disease: In addition, DASH diet consumption significantly reduces AST in patients below 44 years old, 8 weeks' duration of study, baseline serum AST above 28 IU/L, BMI below 30 kg/m2, and patients with NAFLD.